BackContraFect Overview

ContraFect Total Assets

Latest total assets for CFRX: $9.1M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$9.13M
↓ 60.38% YoYΔ $-13.91M vs prior year quarter

Peer average

Loading

ContraFect Total Assets History

Loading

ContraFect vs. peers: Total Assets Comparison

Loading

ContraFect Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ContraFect (CFRX) FAQ

ContraFect (CFRX) currently reports a total assets of $9.1M as of September 2023. That compares with $23M in the prior-year period — down 60.4% year over year. Use the charts on this page to explore ContraFect's total assets history and peer comparisons.

ContraFect's total assets decreased from $23M to $9.1M — a 60.4% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ContraFect reported $9.1M in total assets as of September 2023. That compares with $23M in the prior-year period — down 60.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $9.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ContraFect, and consider following CFRX for alerts when major investors trade the stock.

ContraFect is classified in the Healthcare sector. On total assets, it currently shows $9.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CFRX with unrelated industries.